This company listing is no longer active
CAKF.Y Stock Overview
McKesson Europe AG provides logistics and other services to the pharmaceutical and healthcare sectors worldwide. More details
Snowflake Score | |
---|---|
Valuation | 1/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 4/6 |
Dividends | 1/6 |
McKesson Europe AG Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | €4.10 |
52 Week High | €4.31 |
52 Week Low | €4.02 |
Beta | 0.13 |
11 Month Change | 0% |
3 Month Change | n/a |
1 Year Change | n/a |
33 Year Change | -21.90% |
5 Year Change | -31.09% |
Change since IPO | -47.10% |
Recent News & Updates
Recent updates
Shareholder Returns
CAKF.Y | US Healthcare | US Market | |
---|---|---|---|
7D | 0% | 1.6% | 2.2% |
1Y | n/a | 2.1% | 31.7% |
Return vs Industry: Insufficient data to determine how CAKF.Y performed against the US Healthcare industry.
Return vs Market: Insufficient data to determine how CAKF.Y performed against the US Market.
Price Volatility
CAKF.Y volatility | |
---|---|
CAKF.Y Average Weekly Movement | n/a |
Healthcare Industry Average Movement | 7.0% |
Market Average Movement | 6.3% |
10% most volatile stocks in US Market | 15.8% |
10% least volatile stocks in US Market | 3.1% |
Stable Share Price: CAKF.Y has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine CAKF.Y's volatility change over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1835 | 6,808 | Sebastian Ring | www.mckesson.eu/mck-en |
McKesson Europe AG provides logistics and other services to the pharmaceutical and healthcare sectors worldwide. The company operates through two divisions, Pharmaceutical Distribution and Retail Pharmacy. The Pharmaceutical Distribution division engages in the wholesale of pharmaceutical and other health care products.
McKesson Europe AG Fundamentals Summary
CAKF.Y fundamental statistics | |
---|---|
Market cap | US$5.34b |
Earnings (TTM) | -US$58.93m |
Revenue (TTM) | US$10.05b |
0.5x
P/S Ratio-90.6x
P/E RatioIs CAKF.Y overvalued?
See Fair Value and valuation analysisEarnings & Revenue
CAKF.Y income statement (TTM) | |
---|---|
Revenue | €9.26b |
Cost of Revenue | €8.46b |
Gross Profit | €792.30m |
Other Expenses | €846.60m |
Earnings | -€54.30m |
Last Reported Earnings
Mar 31, 2022
Next Earnings Date
n/a
Earnings per share (EPS) | -0.27 |
Gross Margin | 8.56% |
Net Profit Margin | -0.59% |
Debt/Equity Ratio | 0.3% |
How did CAKF.Y perform over the long term?
See historical performance and comparison